Prevention of clostridium difficile infection with probiotics

Charlesnika T. Evans, Stuart Johnson*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

49 Scopus citations


Despite advances in the diagnosis and treatment of Clostridium difficile infection (CDI) and prevention efforts to reduce the spread of C. difficile, CDI remains a significant challenge to healthcare systems worldwide. Further advances in prevention of CDI may need to focus on those who continue to be exposed to the organism and who are susceptible. Interventions directed toward this susceptible population, particularly hospitalized patients who receive antibiotics, may be effective. There is moderate evidence on the effectiveness of probiotics to prevent primary CDI, but there are few data to support use in secondary prevention of recurrent CDI. This review discusses the literature available on the use of probiotics to prevent primary and secondary CDI.

Original languageEnglish (US)
Pages (from-to)S122-S128
JournalClinical Infectious Diseases
StatePublished - May 15 2015


  • Clostridium difficile
  • meta-analysis
  • probiotics

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Prevention of clostridium difficile infection with probiotics'. Together they form a unique fingerprint.

Cite this